-
公开(公告)号:EP3297679A1
公开(公告)日:2018-03-28
申请号:EP16725810.2
申请日:2016-05-19
申请人: INSERM (Institut National de la Santé et de la Recherche Médicale) , Université Paris Descartes , Université Pierre et Marie Curie (Paris 6) , Université Paris Diderot - Paris 7 , Assistance Publique-Hôpitaux de Paris (APHP)
摘要: The present invention relates to the Transferrin (Tf) or an active fragment thereof for use in the treatment of retinal detachment and/or for use in the treatment of retinal detachment related to other diseases.
-
2.
公开(公告)号:EP2590669B1
公开(公告)日:2016-08-31
申请号:EP11734062.0
申请日:2011-07-11
申请人: INSERM (Institut National de la Santé et de la Recherche Médicale) , Université Paris Descartes , Assistance Publique - Hôpitaux de Paris
CPC分类号: A61K38/40
摘要: Treatment of a disease associated with retinal degenerative disorder. The present invention relates to human Transferrin or an active fragment thereof for use in the treatment of a disease associated with retinal degenerative disorder.
-
3.
公开(公告)号:EP2590669A2
公开(公告)日:2013-05-15
申请号:EP11734062.0
申请日:2011-07-11
CPC分类号: A61K38/40
摘要: Treatment of a disease associated with retinal degenerative disorder. The present invention relates to human Transferrin or an active fragment thereof for use in the treatment of a disease associated with retinal degenerative disorder.
-
-